I don't think they would buy it out right, more likely they would enter into a phase 3 trial funding deal with milestone payments for exclusive US commercial licensing rights.
But that in itself could be worth over $1b USD... and would push the share price up considerably.
So we await the DME results, as you say I don't think timing will have been unduly affected by Covid-19 restrictions.
Heads up: OPT is about to skyrocket, page-35
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
81.5¢ |
Change
0.030(3.82%) |
Mkt cap ! $1.003B | |||
| Open | High | Low | Value | Volume |
| 78.5¢ | 82.5¢ | 78.5¢ | $1.203M | 1.499M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5772 | 81.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 82.5¢ | 844 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| OPT (ASX) Chart |